
Edaravone with and without .6âMg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5)
Keywords: سکته مغزی ایسکمیک حاد; Acute ischemic stroke; edaravone; Japan; prospective observational study; recombinant tissue plasminogen activator; symptomatic intracranial hemorrhage;